Navigation Links
Bionic muscles developed by scientists powered by alcohol and hydrogen

In the direction of development of prosthetic limbs researchers at University of Texas have developed artificial, super-strength muscles which are powered by alcohol and hydrogen. //

As it appears in Science, these artificial muscles are 100 times more powerful than the body's own.

Two types of muscle are being investigated by US researchers at the Nanotech Institute at the University of Texas in Dallas, working with colleagues from South Korea. Both release the chemical energy of fuels, such as hydrogen and alcohol, while consuming oxygen.

The most powerful type, "shorted fuel cell muscles" convert chemical energy into heat, causing a special shape-memory metal alloy to contract.

Another kind of muscle being developed by the team converted chemical energy into electrical energy which caused a material made from carbon nanotube electrodes to bend.

Dr John Madden, from the University of British Columbia in Vancouver, Canada said, "The muscle consumes oxygen and fuel that can be transported via a circulation system; the muscle itself supports the chemical reaction that leads to mechanical work; electrochemical circuits can act as nerves, controlling actuation; some energy is stored locally in the muscle itself; and, like natural muscle, the materials studied contract linearly."
'"/>




Page: 1

Related medicine news :

1. Bionic Women –No longer the Stuff of Science Fictio
2. Bionic Eye may Restore Sight to the Blind
3. Stretching the muscles doesnt make them more resilient
4. Therapeutic cloning by regenerating stem cells from heart muscles
5. New ways developed to understand dyslexia
6. Researchers developed world’s smallest toothbrus
7. Blood test developed for malignant hyperthermia
8. New ultralight hand with better functionality and flexibility developed
9. Novel antibiotic dressing developed for improved wound healing
10. New sensors developed to predict effectiveness of radiotherapy treatment
11. New spinal surgery technique developed by UCSF Surgeon
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... , ... Goodcents Deli Fresh Subs today announced the opening of a new ... St. Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by ... locations in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and ... has selected 21 leaders from government, business and civil society in 11 countries across ... U.S. this fall, engaging in a transformative exchange of knowledge and ideas with the ...
(Date:6/23/2017)... ... , ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an ... 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for ... Denmark in 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in ...
(Date:6/23/2017)... TX (PRWEB) , ... June 23, 2017 , ... All-Star ... to residential and business clients throughout eastern Texas, is announcing the launch of a ... , Recent breast cancer statistics in the United States reveal that an estimated 252, ...
(Date:6/22/2017)... ... 22, 2017 , ... Plastic Surgery Associates is proud to report that founding ... year, research and information firm, Castle Connolly, releases their list of the most notable ... the 3rd time that Dr. Canales has been recognized by Castle Connolly. ...
Breaking Medicine News(10 mins):
(Date:6/19/2017)... , June 19, 2017  Researchers from DRUGSCAN ... that they will host a live, complimentary webinar titled, ... the benchtop to the real world" on Wednesday June ... This webinar will feature interviews with ... look into the manipulation techniques abusers use to prepare ...
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: